Statin induced myopathy: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232128Keywords:
Statins, Creatine kinase, IVIg, Corticosteroid therapyAbstract
Statin-induced necrotizing autoimmune myopathy is an immune-mediated necrotizing myopathy related to the use of statins. It is a very rare disease, which usually presents with proximal muscle weakness and frank elevation in creatine kinase levels. Stopping statin and the use of immunosuppressive therapy are considered the mainstay therapy. Herein, we present a case of a 75-year-old patient with statin-induced myopathy based on the presence of proximal muscle weakness, magnetic resonance findings. The patient was treated with IVIg and corticosteroid therapy with a particularly good response to intravenous immunoglobulin. However, medications are accompanied by the not so friendly adverse events. Through this report we highlight the importance of understanding. This report highlights the importance of timely diagnosis and early use of combined immunosuppressive therapy to improve patients' outcome affected by this rare disease.
Metrics
References
Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation. 2006;114:2788-97.
Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyper-lipidemic patients-the PRIMO study. Cardiovasc. Drugs Ther. 2005;19(6):403-14.
Norata GD, Tibolla G, Catapano AL. Statins and skeletal muscles toxicity: from clinical trials to everyday practice. Pharmacological Res. 2014;88:107-13.
Stenzel W, Goebel HH, Aronica E. Review: immune-mediated necrotizing myopathies-a heterogeneous group of diseases with specific myo pathological features. Neuropathol Appl Neurobiol. 2012;38:632-46
Qu H, Guo M, Kou N, Wu HT, Zhang Y, Gao ZY, Shi DZ. Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report. J Clin Pharm Ther. 2016;41(5):568-71.
Alfirevic A, Neely D, Armitage J, Chinoy H, Cooper RG, Laaksonen R et al. Phenotype standardization for statin-induced myotoxicity. Clin Pharmacol Ther. 2014;96:470-76.
Hamann PD, Cooper RG, McHugh NJ, Chinoy H. Statin-induced necrotizing myositis-a discrete autoimmune entity within the “statin-induced myopathy spectrum. Autoimmun Rev. 2013;12:1177-81.
Neuromuscular Disorders and Peripheral Neuropathies. Available at: https://www.frontiersin.org/journals/neurology/sections/neuromuscular-disorders-and-peripheral-neuropathies. Accessed on 25 April, 2023.
Do myositis-specific antibodies have an impact on the treatment of idiopathic inflammatory myopathies? Available at: https://rheumatology.medicinematters.com/myositis/diagnosis-and-screening/myositis-specific-antibodies-idiopathic-inflammatory-myopathies/17556384. Accessed on 25 April, 2023.
Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, De Visser M et al. 5EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups. Ann Rheum Dis. 2017;76(12):1955-64.
Downloads
Published
How to Cite
Issue
Section
